Company: CDT
Filing Date: 2025-04-16
Form Type: PRE 14A
Source: 0001641172-25-005096
Chunk: 7

Company: CDT Equity Inc.
Filing Date: 2025-04-16
Form: PRE 14A
Chunk 7
---
 vote all of your shares of Common Stock.

Delivery of Documents to Stockholders Sharing an Address

A number of brokers with account holders who are stockholders of the Company will be “householding” our proxy materials. A single set of the proxy materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be “householding” communications to your address, “householding” will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in “householding” and would prefer to receive separate proxy materials, please notify your broker or direct a written request to Conduit Pharmaceuticals Inc., 4581 Tamiami Trail North, Suite 200, Naples, Florida, 34103, attention: Corporate Secretary. Stockholders who currently receive multiple copies of the proxy materials at their address and would like to request “householding” of their communications should contact their broker.

For Assistance with Technical Difficulties at the Special Meeting

If you encounter any difficulties accessing the virtual meeting during the check-in or meeting time, please call (888) 799-9666.

| 4 |

<div align='center'>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth beneficial ownership of the Company’s Common Stock as of April 21, 2025 by:

| ● | each                                                                                                    
 person known to be the beneficial owner of more than 5% of the outstanding Common Stock of the Company; |
| ● | each                                                                                                    
 of the Company’s current executive officers and directors; and                                          |
| ● | all                                                                                                     
 of the Company’s current executive officers and directors as a group.                                   |

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security. Under those rules, beneficial ownership includes securities that the individual or entity has the right to acquire, such as through the exercise of warrants or stock options or the vesting of restricted stock units, within 60 days of April 21, 2025. Shares subject to warrants or options that are currently exercisable or exercisable within 60 days of April 21, 2025 or subject to restricted stock units that vest within 60 days of April 21, 2025 are considered outstanding